Abiraterone Acetate Tablet
Product Images NDC 16714-963

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 16714-963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Label for Abiraterone Acetate Tablets, USP 250 mg oral tablets. The package contains 120 film-coated tablets. Manufactured by Dr. Reddy's Laboratories Limited and labeled for NorthStar Rx LLC. The label includes storage instructions, dosage information reference, a warning for pregnant women handling the drug, and barcode with NDC 16714-963-01.*

FDA Label Image

Figure1 (Figure1)

A survival curve chart comparing the percentage of survival over time in months for Abiraterone Acetate versus Placebo. The x-axis represents time to death in months, and the y-axis shows percent survival, with two lines indicating survival rates for the two groups.*

FDA Label Image

Figure2 (Figure2)

A survival curve chart comparing the percentage of subjects without death over months from randomization between Abiraterone Acetate and placebo groups. The horizontal axis shows time in months, while the vertical axis shows the percentage of subjects alive. Two lines represent each group, with data points marking the number of subjects at risk over time.*

FDA Label Image

Figure3 (Figure3)

A Kaplan-Meier survival curve chart comparing the percentage of subjects without radiographic progression or death over time (months from randomization) between two groups: Abiraterone Acetate and Placebo. The chart shows the number of subjects at risk at different time points for both groups, with Abiraterone Acetate represented by a solid line and Placebo by a dashed line.*

FDA Label Image

Figure4

A Kaplan-Meier survival curve comparing the percentage of subjects without death over months from randomization between Abiraterone Acetate and placebo groups. The x-axis shows time in months up to 66, and the y-axis shows survival percentage from 0 to 100%. The graph includes a table of subjects at risk at various time points for both groups.*

FDA Label Image

Structure (Structure)

Chemical structure of Abiraterone Acetate, a steroidal molecule with a pyridine ring, hydroxyl group, and acetate ester functional groups, as displayed in a 2D molecular diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.